Delivery Order SPE2DB20D3303-SPE2DB24FY4D3

Award Date 11/30/23
Potential Completion Date 12/1/23
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,101.81, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,189.19 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive transdermal patch. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.49 fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive medication. The contract has an ultimate completion date of January 5, 2024 and was awarded on January 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The $7,630.15 Firm Fixed Price Delivery Order contract is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a type of contraceptive patch, with a period of performance through January 5, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.14 firm-fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The contract has an ultimate completion date of November 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,666.66 firm-fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The contract has an ultimate completion date of November 4, 2024 and was awarded on November 1, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,268.37, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a type of contraceptive patch. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 30, 2024. The contract was awarded on May 29, 2024 and does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,301.88 Firm Fixed Price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The award is not associated with a set-aside designation. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $35,338.15 firm fixed-price contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive medication. The award, valued at $4,267.69, is a delivery order with a firm fixed price and an ultimate completion date of September 28, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FY4D3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,582.35 delivery order contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a type of contraceptive patch. The contract has a period of performance that runs through December 1, 2023 and uses a Firm Fixed Price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 5/12/25, 10:42 AM